Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hey, Dogger!Check out this CVSI move:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168513218
700 shares of preferred stock with 170,000 votes per share to ensure passage of 1. increase in number of capital and common shares and 2. approval of reverse stock split.
CV Sciences' BOARD PURGE and CALCIFICATION
CV Sciences' 04/05/2022 14A p12:
CV Sciences' STOCKHOLDER NULLIFICATION with DILUTION
CV Sciences' FY2021 10-K:
"SUBSTANTIAL DOUBT": CVSciences as a "GOING CONCERN"
That DOUBT was CLEARLY EXPRESSED in the 04/04/2022 10-K by both the Auditor, HASKELL & WHITE, and CV Sciences Management.
Search CV Sciences' 10-K for "going concern" and you'll find 9 matches:
View those 9 matches of "going concern" on the following pages of that 10-k:
Page 17 Page 29 Page 38 Page 62
As for a comparison with Charlotte's Web:
Here's a screenshot showing the search results for "going concern" in Charlotte's Web's 03/24/22 10-K
NOTE: "Phrase not found".
Unlike CV Sciences, there are NO WARNING FLAGS regarding Charlotte's Web as a "going concern".
Given: "SUBSTANTIAL DOUBT" about CVSciences SURVIVAL
you're comparing APPLES (CW) to TRASH (CV).
From CV Sciences' April 4 10-K:
and
CVSciences' BIG CATALYSTS?! LOL!
CBD+NICOTINE ?! "CVSI-007" has been "dangling" for SIX(6) years with NO DEVELOPMENT.
CV Sciences' Long Decline ACCELERATED in Q4
CV Sciences' FY2021 10-K
CVSI has been on a decline for years. But in Q4 STOCKHOLDER EQUITY DROPPED NEARLY 70% .
Only "SHARES OUTSTANDING" is increasing, i.e., DILUTION :
(Note: Check out the April 05 PRE 14A: As of March 31, 2022 Shares Outstanding had grown to 122M with plans for MUCH MORE DILUTION in the near-term.)
CV Sciences
STOCKHOLDER SHARES
REVENUES CASH EQUITY OUTSTANDING
( $M ) ( $M ) ( $M ) ( M )
2018
Q2 12.3 7.2 21.8 90.9
Q3 13.6 11.0 25.8 94.6
Q4 14.2 12.7 30.1 94.9
2019
Q1 14.9 13.6 30.9 98.5
Q2 16.9 15.7 34.3 98.7
Q3 12.6 14.2 33.2 98.8
Q4 9.4 9.6 29.1 99.4
2020
Q1 8.3 7.6 25.4 99.9
Q2 5.4 8.1 * 22.0 99.9
Q3 5.6 6.1 * 19.4 100.0
Q4 5.2 4.5 * 11.2 100.7
2021
Q1 4.8 5.7 * 12.0 106.8
Q2 5.1 3.0 * 10.0 108.5
Q3 5.1 1.7 * 11.1 109.9
Q4** 5.0 1.4 3.5 112.5
^
^
^
Stockholder Equity
Reduced by ~70% in one quarter.
SERIOUSLY ??!! Bad news over??!!
CV Sciences "got the bad news over with" ??!! LOL!!
14A: CVSciences' BOD: 5-3+1=WHO?
Here are two(2) excerpts from CV Sciences' 04/05/2022 14A:
and
10-K: CV Sciences' SHAREHOLDER NULLIFICATION with DILUTION
Here's a pertinent excerpt from CV Sciences' FY2021 10-K:
10-K: CV Sciences' DILUTION TIMES TWO(2)
Here are two(2) excerpts from CV Sciences' FY2021 10-K:
and
10-K:"SUBSTANTIAL DOUBT" about CVSciences' SURVIVAL
Here are two(2) excerpts from CV Sciences' April 4 10-K:
and
CVSciences' CASH?! LOL! $1.4M !!
ap17 mentioned CV Sciences' "cash".
As bad as CVSI's cash position of $1.4M is in isolation, it's MUCH WORSE when viewed in the broader context of CV Sciences' overall decline as a viable business.
CV Sciences' Long Decline ACCELERATED in Q4
CV Sciences' FY2021 10-K
CVSI has been on a decline for years. But in Q4 STOCKHOLDER EQUITY DROPPED NEARLY 70% .
Only "SHARES OUTSTANDING" is increasing, i.e., DILUTION :
(Note: Check out the April 05 PRE 14A: As of March 31, 2022 Shares Outstanding had grown to 122M with plans for MUCH MORE DILUTION in the near-term.)
CV Sciences
STOCKHOLDER SHARES
REVENUES CASH EQUITY OUTSTANDING
( $M ) ( $M ) ( $M ) ( M )
2018
Q2 12.3 7.2 21.8 90.9
Q3 13.6 11.0 25.8 94.6
Q4 14.2 12.7 30.1 94.9
2019
Q1 14.9 13.6 30.9 98.5
Q2 16.9 15.7 34.3 98.7
Q3 12.6 14.2 33.2 98.8
Q4 9.4 9.6 29.1 99.4
2020
Q1 8.3 7.6 25.4 99.9
Q2 5.4 8.1 * 22.0 99.9
Q3 5.6 6.1 * 19.4 100.0
Q4 5.2 4.5 * 11.2 100.7
2021
Q1 4.8 5.7 * 12.0 106.8
Q2 5.1 3.0 * 10.0 108.5
Q3 5.1 1.7 * 11.1 109.9
Q4** 5.0 1.4 3.5 112.5
^
^
^
Stockholder Equity
Reduced by ~70% in one quarter.
Butt, why pass up the FREE CASH?
ap17 said:
The settlement is SOMETHING. Why pass?
ap17 said:
No problem
When one(1) preferred share casts 170,000 votes, it's a "distinction without a/much difference".
I asked: "IS THIS LEGAL ???"
I, like others weighing in, AM NO LAWYER and I also, like others, now believe IT IS LEGAL.
The following screenshots are from the July 26, 2011 Foreclosure Solutions, Inc. SEC S-1/A (Remember that was CV Sciences' name originally.)
and
Though that S-1/A references "Texas" incorporation, I'm confident the eventual "CV Sciences" became a Delaware corporation.
Check out the following article: Delaware Blank Check Preferred Stock
MUCH MORE IMPORTANT in latest 8-K!
ir.cvsciences.com/all-sec-filings/content/0001510964-22-000023/0001510964-22-000023.pdf
CVSciences' Long Decline ACCELERATED in Q4
CV Sciences' FY2021 8-K
CVSI has been on a decline for years. But in Q4 STOCKHOLDER EQUITY DROPPED NEARLY 70% .
Only "SHARES OUTSTANDING" is increasing, i.e., DILUTION :
CV Sciences
STOCKHOLDER SHARES
REVENUES CASH EQUITY OUTSTANDING
( $M ) ( $M ) ( $M ) ( M )
2018
Q2 12.3 7.2 21.8 90.9
Q3 13.6 11.0 25.8 94.6
Q4 14.2 12.7 30.1 94.9
2019
Q1 14.9 13.6 30.9 98.5
Q2 16.9 15.7 34.3 98.7
Q3 12.6 14.2 33.2 98.8
Q4 9.4 9.6 29.1 99.4
2020
Q1 8.3 7.6 25.4 99.9
Q2 5.4 8.1 * 22.0 99.9
Q3 5.6 6.1 * 19.4 100.0
Q4 5.2 4.5 * 11.2 100.7
2021
Q1 4.8 5.7 * 12.0 106.8
Q2 5.1 3.0 * 10.0 108.5
Q3 5.1 1.7 * 11.1 109.9
Q4** 5.0 1.4 3.5 112.5
^
^
^
Stockholder Equity
Reduced by ~70% in one quarter.
(Makes Charlotte's write-down look small. LOL.)
CV Sciences' OUTSOURCING:
If you use your handy dandy illuminated jewelers eye loupe magnifier you can read the following in many (most? all??) CV Sciences product descriptions:
Expand Overseas?! LOL CVSciences is barely surviving!!
CVSI HAS BEEN ON A DECLINE FOR YEARS.
Only "SHARES OUTSTANDING" is increasing, i.e., DILUTION :
CV Sciences
SHAREHOLDER SHARES
REVENUES CASH EQUITY OUTSTANDING
( $M ) ( $M ) ( $M ) ( M )
2018
Q2 12.3 7.2 21.8 90.9
Q3 13.6 11.0 25.8 94.6
Q4 14.2 12.7 30.1 94.9
2019
Q1 14.9 13.6 30.9 98.5
Q2 16.9 15.7 34.3 98.7
Q3 12.6 14.2 33.2 98.8
Q4 9.4 9.6 29.1 99.4
2020
Q1 8.3 7.6 25.4 99.9
Q2 5.4 8.1 * 22.0 99.9
Q3 5.6 6.1 * 19.4 100.0
Q4 5.2 4.5 * 11.2 100.7
2021
Q1 4.8 5.7 * 12.0 106.8
Q2 5.1 3.0 * 10.0 108.5
Q3 5.1 1.7 * 11.1 109.9
Q4 ? ? ? ? <== TBA AFTER MARKET CLOSES 03/31/22
CV Sciences' Long Decline
CVSI HAS BEEN ON A DECLINE FOR YEARS.
Only "SHARES OUTSTANDING" is increasing, i.e., DILUTION :
CV Sciences
SHAREHOLDER SHARES
REVENUES CASH EQUITY OUTSTANDING
( $M ) ( $M ) ( $M ) ( M )
2018
Q2 12.3 7.2 21.8 90.9
Q3 13.6 11.0 25.8 94.6
Q4 14.2 12.7 30.1 94.9
2019
Q1 14.9 13.6 30.9 98.5
Q2 16.9 15.7 34.3 98.7
Q3 12.6 14.2 33.2 98.8
Q4 9.4 9.6 29.1 99.4
2020
Q1 8.3 7.6 25.4 99.9
Q2 5.4 8.1 * 22.0 99.9
Q3 5.6 6.1 * 19.4 100.0
Q4 5.2 4.5 * 11.2 100.7
2021
Q1 4.8 5.7 * 12.0 106.8
Q2 5.1 3.0 * 10.0 108.5
Q3 5.1 1.7 * 11.1 109.9
Q4 ? ? ? ? <== TBA AFTER MARKET CLOSES 03/31/22
Think: SHARES not Dollars
The Ina Settlement ($712,500.00) will require cash-strapped CV Sciences to compensate for that cash outlay by using proceeds from its dilutive offerings -- the most recent announced March 25.
Given the conversion price terms and the "full-ratchet" provision, that $712,500.00 settlement currently is equivalent to approximately 5 MILLION SHARES -- more if the CVSI shareprice continues to fall.
Such a "small" settlement yet SO MUCH DILUTION!
That cartoon belongs to ALL CVSI Bagholders
CV Sciences' CASH BURN: Ina Settlement
Summary of CVSI's LATEST DILUTION:
https://ir.cvsciences.com/all-sec-filings/content/0001510964-22-000006/0001510964-22-000006.pdf
Note the "full-ratchet" provision, described by "vcexperts.com" as follows:
Old (essentially CYA boilerplate) News
These SAME "interesting items", including the "biggie" were included in the filing for the previous year, FY2020, on Sedar.
https://www.sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00045471
CORRECTION: CVSI's Shareholders Equity DECREASED 62%